Drug Discovery World
JULY 18, 2022
Big data and AI are all the rage. But, beyond these buzzwords and the quantity of data, what’s next for these powerful tools? His work provides insight into AI and big data in relation to pharma and drug discovery– now and in the future. “AI
pharmaphorum
FEBRUARY 1, 2022
Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
DECEMBER 27, 2023
In this episode, Kelland shares what she means by the ‘next pandemic’, the lessons learnt from the Covid-19 pandemic, and the role of global health organisations and pharma companies going forward. A deep dive into US drug discovery What lies in the future for genomics and big data? Listen here.
Drug Discovery World
FEBRUARY 6, 2024
Biopharma and biotech companies without these capabilities are keen to harness these technologies and the number of strategic partnerships with such companies is accelerating at an unprecedented rate. Digital tech is also helping researchers to find target candidates for some of the most challenging disease areas.
pharmaphorum
FEBRUARY 11, 2022
Sun says because of this, Komodo engineered solutions or apps that “do certain things for end-users applied against the Healthcare Map.”. Therefore, organisations can determine how they’d like to use the Map’s data then create a software solution that helps them do so. About the author.
Expert insights. Personalized for you.
52 
Let's personalize your content